Sign in
ONVO Stock Price, Chart, Stats & News
Organovo Holdings, Inc.
Save
3.67M
Market cap
–
Current P/E
–
Forward P/E
ONVO chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 85.21% |
Operating margin | -8066.20% |
Pretax margin | -865.49% |
Net margin | -864.08% |
Effective tax rate | 0.16% |
ROA | -17.63% |
ROE | -15.56% |
D/E | 0.13x |
Interest coverage ratio | -2290.80x |
ONVO valuation
P/E | – |
P/S | 25.86x |
P/B | 1.20x |
P/CF | -0.50x |
P/FCF | -0.35x |
P/OCF | -0.50x |
PEG | 0.22x |
EV multiple | -5.98x |
About
Organovo Holdings, Inc. is a biotechnology firm that specializes in engineering sophisticated 3D tissues designed to accurately mimic critical facets of human diseases. Central to its operations is a comprehensive 3D human tissue platform, which features the company's proprietary NovoGen Bioprinters. These automated devices are crucial for fabricating complex, living 3D tissues from mammalian cells.
Similar securities
Based on sector and market capitalization
Report issue